Angiosarcoma Treatment Market Players:
- F. Hoffmann La Roche Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Novartis AG
- Bayer AG
- GlaxoSmithKline plc.
- Sanofi S.A.
- Amgen Inc.
- Merck & Co. Inc.
- AbbiVie Inc.
- Eli Lilly and Company
- Bausch Health
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of angiosarcoma treatment is evaluated at USD 307.25 million.
The global angiosarcoma treatment market size was worth over USD 292.76 million in 2025 and is poised to grow at a CAGR of around 5.5%, reaching USD 500.08 million revenue by 2035.
By 2035, North America is anticipated to command a 35% share of the angiosarcoma treatment market, attributed to advancing medical infrastructure and supportive government R&D policies.
Key players in the market include Bayer AG, GlaxoSmithKline plc., Sanofi S.A., Amgen Inc., Merck & Co. Inc., AbbiVie Inc., Eli Lilly and Company, Bausch Health.
